Gluten-free and casein-free diets found not to affect behavior of autistic children

Summary: No significant behavioral changes and no association with urinary beta-casomorphin concentrations were found in children on the autism spectrum who were fed a gluten-free or casein-free diet.

Source: University of Granada

A study by researchers from the Department of Psychiatry at the University of Granada (UGR) has analyzed the effects of a gluten-free diet and a casein-free diet (that is, one with no milk protein) on the behavior of children diagnosed with autism spectrum disorders.

Given the limitations of attempts to treat such disorders, many families turn to alternative therapies. Among these, gluten- and casein-free diets implemented as a therapeutic approach in autism-spectrum disorders have been the subject of significant interest and controversy in scholarly research. Some authors have found such diets to have favorable effects on the symptoms of autism, while others–particularly the more recent studies–have found no conclusive results.

Research conducted at the UGR reaffirms that gluten- and casein-free diets are not helpful as a standardized treatment for all children diagnosed with an autism spectrum disorder. It may be that those cases with associated gastrointestinal disorders may benefit from such an approach.

Beta-casomorphin is a peptide (amino acid-binding), so-called for its morphine-like opioid activity, which is formed in the intestine due to abnormal digestion of cow’s milk protein (casein). People with autism-spectrum disorders may present an abnormal porosity in the intestinal barrier that enables beta-casomorphin to penetrate the barrier, enter the blood circulation and, from there, reach the central nervous system, producing a toxic effect. Some scientists who have identified peptiduria (the abnormal presence of peptides in the urine) in children with autism spectrum disorders have detected a reduction of these peptides in subjects who have followed the gluten- and casein-free diet.

The primary aim of this research was twofold: to determine if gluten- and casein-free diets decrease behavioral disorders among children and adolescents diagnosed with autism spectrum disorders, and to examine whether there is a link between possible behavioral changes after implementing this diet and levels of beta-casomorphin found in urine.

Two studies and a sample of over 60 young people

The UGR research comprised two studies. First, a pilot clinical assay was carried out on 28 children and adolescents diagnosed with autism spectrum disorders, who followed a gluten-free diet for three months and then switched to a casein-free diet for a further three months.

Next, a second study was initiated, funded by the Spanish Association of Child and Adolescent Psychiatry (AEPNyA), in which 37 children and adolescents diagnosed with autism-spectrum disorders participated. This sample followed the same procedure, except for a longer duration (one special diet for six months, then the other special diet, again for six months). Variables relating to the efficacy, risk, and safety of following these diets were studied.

This shows a child coloring with crayons

Research conducted at the UGR reaffirms that gluten- and casein-free diets are not helpful as a standardised treatment for all children diagnosed with an autism-spectrum disorder. It may be that those cases with associated gastrointestinal disorders may benefit from such an approach. Image is in the public domain.

In neither of the two studies (3 + 3 months vs. 6 + 6 months) were significant changes detected either in the behavioral scales or in the beta-casomorphin levels in urine after the subjects had followed the gluten-free and the casein-free diet.

The principal investigator on this project, Pablo José González Domenech, of the Department of Psychiatry of the UGR, notes that further research is necessary. In addition to eliminating gluten and casein for a sufficient period of time (at least six months), future studies should include placebo and double-blind elements, as well as other biological markers to better define the subjects who may benefit from these diets.

To identify potential users, it would be interesting to include among the evaluation criteria measurements of intestinal permeability, examinations of intestinal bacterial populations, and gastrointestinal enzymatic and inflammatory activity, and to conduct brain imaging tests for the study of possible structural and functional changes.

About this diet and asd research article

Source:
University of Granada
Media Contacts:
Pablo J. González Domenech – University of Granada
Image Source:
The image is in the public domain.

Original Research: Closed access
“Influence of a Combined Gluten-Free and Casein-Free Diet on Behavior Disorders in Children and Adolescents Diagnosed with Autism Spectrum Disorder: A 12-Month Follow-Up Clinical Trial”. Pablo José González-Domenech, Francisco Díaz Atienza, Carlos García Pablos, María Luisa Fernández Soto, José María Martínez-Ortega, Luis Gutiérrez-Rojas.
Journal of Autism and Developmental Disorders doi:10.1007/s10803-019-04333-1.

Abstract

Influence of a Combined Gluten-Free and Casein-Free Diet on Behavior Disorders in Children and Adolescents Diagnosed with Autism Spectrum Disorder: A 12-Month Follow-Up Clinical Trial

The use of alternative interventions, such as gluten-free and casein-free (GFCF) diets, is frequent due to limited therapies for Autism Spectrum Disorder (ASD). Our aims were to determine the influence of a GFCF diet on behavior disorders in children and adolescents diagnosed with ASD and the potential association with urinary beta-casomorphin concentrations. Thirty-seven patients were recruited for this crossover trial. Each patient consumed a normal diet (including gluten and casein) for 6 months and a GFCF diet for another 6 months. The order of the intervention (beginning with normal diet or with GFCF diet) was assigned randomly. Patients were evaluated at three time-points (at the beginning of the study, after normal diet and after GFCF diet). Questionnaires regarding behavior and autism and dietary adherence were completed and urinary beta-casomorphin concentrations were determined at each time-point. No significant behavioral changes and no association with urinary beta-casomorphin concentrations were found after GFCF diet. A 6-month GFCF diet do not induce significant changes in behavioral symptoms of autism and urinary beta-casomorphin concentrations. Further studies with a long follow-up period similar to ours and including placebo and blinding elements are needed to identify better those respondents to GFCF diets.

Feel free to share this Autism News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.com
We hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.
No more articles